2. Cancer is the
Epidemic of
our Time
The disease is
deeply personal to
every one of us
because someone
we know has likely
battled it.
3. Leading to the creation of one of the
most important Initiatives …
4. What is Cancer Moonshot?
On January 2016, the White House announced its aim
to deliver a decade’s worth of advances in cancer
prevention, diagnosis, and treatment, in five years
with this initiative.
5.
6. This initiative includes the building of an
AI framework named CANDLE (Cancer
Distributed Learning Environment) being
developed by multiple organizations.
It will help us change the
way we understand cancer.
READ MORE
7.
8. “GPU Deep Learning has given us a new tool to tackle grand
challenges that have, up to now, been too complex for even
the most powerful supercomputers. Together with the
Department of Energy and the National Cancer Institute we
are creating an AI supercomputing platform for cancer
research.”
- Jen-Hsun Huang
CEO at NVIDIA
SC16
READ MORE
9. “Big Data and Computing Power
together provide the possibility of
significant insight into how
genomics, family medical history,
lifestyles, genetic changes can
trigger cancer and how the cancers
can be treated.”
- Joe Biden
Vice President of the United States
CIO Interview
READ MORE
10.
11. The bright future of AI in healthcare only
continues to become more and more
prominent …
Enlitic
Imaging & Diagnostics
Insilico Medicine
Drug Discovery
Pathway Genomics
Imaging & Diagnostics
READ MORE
12. “Let's say a patient gets a lung CT screening. Enlitic's software could
"read" the CT scan and determine the probability that the patient has
lung cancer, find clinically similar patients, and show their treatments
and outcomes. The clinician could use this information to decide
whether or not to perform a biopsy. By immediately giving the
clinician the most accurate information, the patient is less likely to
have a missed diagnosis or an unneeded biopsy.”
Enlitic applies the state of the art in deep learning
technology to medicine.
- Jeremy Howard
Founder and CEO of Enlitic
IDG Connect Interview
13. “At Insilico we are working on a system to discover candidates
and repurposing candidates that are most efficacious and least
toxic to specific diseases and looking for new approaches to
treat individual patients with rare diseases.
- Alex Zharvoronkov
CEO at Insilico Medicine
RE-WORK Interview
Insilico Medicine applies Deep Learning algorithms to drug
discovery for various applications .
14. “We are in the process of initiating additional disease specific
studies for early cancer detection in high risk patients,
including a study in lung cancer, and will present and publish
the data in the appropriate forums.””
- Glenn Braunstein
Chief Medical Officer at Pathway Genomics
Press Release
Pathway Genomics developed blood test kit, CencerIntercept
Detect, with IBM Watson to test early cancer detection.
15. LEARN MORE ABOUT HOW THE WORLD OF
HEALTHCARE IS BEING TRANSFORMED BY AI
LEARN MORE